Cargando…

Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP

AIMS: Evidence on the risk factors for incident heart failure in Asia has been limited. We sought to identify the risk factors for pre‐heart failure or symptomatic heart failure, based on N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), in the Japanese general population. METHODS: We performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Shoko, Yamagishi, Kazumasa, Kihara, Tomomi, Tanaka, Mari, Imano, Hironori, Muraki, Isao, Shimizu, Yuji, Hayama‐Terada, Mina, Umesawa, Mitsumasa, Sankai, Tomoko, Okada, Takeo, Kitamura, Akihiko, Kiyama, Masahiko, Iso, Hiroyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871651/
https://www.ncbi.nlm.nih.gov/pubmed/36151844
http://dx.doi.org/10.1002/ehf2.14149
_version_ 1784877225079734272
author Aoki, Shoko
Yamagishi, Kazumasa
Kihara, Tomomi
Tanaka, Mari
Imano, Hironori
Muraki, Isao
Shimizu, Yuji
Hayama‐Terada, Mina
Umesawa, Mitsumasa
Sankai, Tomoko
Okada, Takeo
Kitamura, Akihiko
Kiyama, Masahiko
Iso, Hiroyasu
author_facet Aoki, Shoko
Yamagishi, Kazumasa
Kihara, Tomomi
Tanaka, Mari
Imano, Hironori
Muraki, Isao
Shimizu, Yuji
Hayama‐Terada, Mina
Umesawa, Mitsumasa
Sankai, Tomoko
Okada, Takeo
Kitamura, Akihiko
Kiyama, Masahiko
Iso, Hiroyasu
author_sort Aoki, Shoko
collection PubMed
description AIMS: Evidence on the risk factors for incident heart failure in Asia has been limited. We sought to identify the risk factors for pre‐heart failure or symptomatic heart failure, based on N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), in the Japanese general population. METHODS: We performed a retrospective cohort study based on the Circulatory Risk in Communities Study involving 5335 Japanese individuals whose NT‐proBNP levels were measured between 2010 and 2015. Of these, 2768 people aged between 30 and 69 years who undertook annual cardiovascular risk surveys at least once between 1990 and 2000 were retrospectively eligible to be participants in this study. We performed multivariable logistic regression analyses to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) of pre‐heart failure or symptomatic heart failure defined as NT‐proBNP >400 pg/mL or as having a diagnosis of heart failure and taking medication for heart failure for several cardiovascular risk factors (body mass index, blood pressure, diabetes mellitus, total cholesterol, triglyceride, smoking status, drinking status). RESULTS: We identified 85 cases of heart failure. The multivariable ORs (95% CIs) were 5.70 (2.70–12.0) for body mass index of 27–29.9 kg/m(2) and 5.91 (2.19–16.0) for ≥30 kg/m(2) compared with 21–22.9 kg/m(2); 2.49(1.01–6.13) for systolic blood pressure of ≥160 mmHg vs. <130 mmHg; 2.87(1.23–6.68) for diastolic blood pressure of ≥100 mmHg vs. <80 mmHg; 5.16(2.14–12.4) for diabetes vs. non‐diabetes; and 2.24 (0.92–5.49) for current smokers of ≥20 cigarettes/day vs. never smokers. The multivariable ORs (95% CIs) of the number of risk factors, defined as the sum of four risk factors (obesity, hypertension, diabetes, and current smoker) was 6.80 (3.69–12.5) for ≥2 risk factors vs. no risk factors. CONCLUSIONS: The accumulation of these risk factors was associated with a graded higher risk of pre‐heart failure or symptomatic heart failure.
format Online
Article
Text
id pubmed-9871651
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98716512023-01-25 Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP Aoki, Shoko Yamagishi, Kazumasa Kihara, Tomomi Tanaka, Mari Imano, Hironori Muraki, Isao Shimizu, Yuji Hayama‐Terada, Mina Umesawa, Mitsumasa Sankai, Tomoko Okada, Takeo Kitamura, Akihiko Kiyama, Masahiko Iso, Hiroyasu ESC Heart Fail Original Articles AIMS: Evidence on the risk factors for incident heart failure in Asia has been limited. We sought to identify the risk factors for pre‐heart failure or symptomatic heart failure, based on N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), in the Japanese general population. METHODS: We performed a retrospective cohort study based on the Circulatory Risk in Communities Study involving 5335 Japanese individuals whose NT‐proBNP levels were measured between 2010 and 2015. Of these, 2768 people aged between 30 and 69 years who undertook annual cardiovascular risk surveys at least once between 1990 and 2000 were retrospectively eligible to be participants in this study. We performed multivariable logistic regression analyses to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) of pre‐heart failure or symptomatic heart failure defined as NT‐proBNP >400 pg/mL or as having a diagnosis of heart failure and taking medication for heart failure for several cardiovascular risk factors (body mass index, blood pressure, diabetes mellitus, total cholesterol, triglyceride, smoking status, drinking status). RESULTS: We identified 85 cases of heart failure. The multivariable ORs (95% CIs) were 5.70 (2.70–12.0) for body mass index of 27–29.9 kg/m(2) and 5.91 (2.19–16.0) for ≥30 kg/m(2) compared with 21–22.9 kg/m(2); 2.49(1.01–6.13) for systolic blood pressure of ≥160 mmHg vs. <130 mmHg; 2.87(1.23–6.68) for diastolic blood pressure of ≥100 mmHg vs. <80 mmHg; 5.16(2.14–12.4) for diabetes vs. non‐diabetes; and 2.24 (0.92–5.49) for current smokers of ≥20 cigarettes/day vs. never smokers. The multivariable ORs (95% CIs) of the number of risk factors, defined as the sum of four risk factors (obesity, hypertension, diabetes, and current smoker) was 6.80 (3.69–12.5) for ≥2 risk factors vs. no risk factors. CONCLUSIONS: The accumulation of these risk factors was associated with a graded higher risk of pre‐heart failure or symptomatic heart failure. John Wiley and Sons Inc. 2022-09-24 /pmc/articles/PMC9871651/ /pubmed/36151844 http://dx.doi.org/10.1002/ehf2.14149 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Aoki, Shoko
Yamagishi, Kazumasa
Kihara, Tomomi
Tanaka, Mari
Imano, Hironori
Muraki, Isao
Shimizu, Yuji
Hayama‐Terada, Mina
Umesawa, Mitsumasa
Sankai, Tomoko
Okada, Takeo
Kitamura, Akihiko
Kiyama, Masahiko
Iso, Hiroyasu
Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
title Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
title_full Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
title_fullStr Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
title_full_unstemmed Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
title_short Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
title_sort risk factors for pre‐heart failure or symptomatic heart failure based on nt‐probnp
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871651/
https://www.ncbi.nlm.nih.gov/pubmed/36151844
http://dx.doi.org/10.1002/ehf2.14149
work_keys_str_mv AT aokishoko riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT yamagishikazumasa riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT kiharatomomi riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT tanakamari riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT imanohironori riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT murakiisao riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT shimizuyuji riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT hayamateradamina riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT umesawamitsumasa riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT sankaitomoko riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT okadatakeo riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT kitamuraakihiko riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT kiyamamasahiko riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp
AT isohiroyasu riskfactorsforpreheartfailureorsymptomaticheartfailurebasedonntprobnp